Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy
- PMID: 19581651
- DOI: 10.7326/0003-4819-151-1-200907070-00016
Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy
Comment on
-
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.Ann Intern Med. 2009 Jan 20;150(2):73-83. doi: 10.7326/0003-4819-150-2-200901200-00005. Ann Intern Med. 2009. PMID: 19153410
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical